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CLINICAL RESEARCH ARTICLE
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ABSTRACT
Background: Childhood maltreatment (CM) is associated with impaired hypothalamic- 
pituitary-adrenal (HPA) axis negative feedback and cognitive dysfunction, resembling 
those abnormalities linked to major depressive disorder (MDD).
Objectives: We aimed to assess the potential modulating effects of MDD diagnosis or HPA 
axis function in the association between different types of CM and cognitive performance in 
adulthood.
Methods: Sixty-eight MDD patients and 87 healthy controls were recruited. CM was 
assessed with the Childhood Trauma Questionnaire. We obtained three latent variables for 
neuropsychological performance (verbal memory, visual memory and executive function/ 
processing speed) after running a confirmatory factor analysis with cognitive tests applied. 
Dexamethasone suppression test ratio (DSTR) was performed using dexamethasone 
0.25 mg.
Results: Different types of CM had different effects on cognition, modulated by MDD 
diagnosis and HPA axis function. Individuals with physical maltreatment and MDD pre-
sented with enhanced cognition in certain domains. The DSTR differentially modulated the 
association between visual memory and physical neglect or sexual abuse.
Conclusions: HPA axis-related neurobiological mechanisms leading to cognitive impairment 
might differ depending upon the type of CM. Our results suggest a need for early assess-
ment and intervention on cognition and resilience mechanisms in individuals exposed to 
CM to minimize its deleterious and lasting effects.
El maltrato infantil interactúa con la retroalimentación negativa del 
eje hipotalámico-hipofisario-adrenal y la depresión mayor: efectos 
sobre el rendimiento cognitivo.
Antecedentes: El maltrato infantil (MI) se asocia con una alteración en la retroalimentación 
negativa del eje hipotalámico-hipofisario-adrenal (HHA) y disfunción cognitiva, que se 
asemejan a las anomalías vinculadas al trastorno depresivo mayor (TDM).
Objetivos: Nuestro objetivo fue evaluar los posibles efectos moduladores del diagnóstico de 
TDM y de la función del eje HHA en la asociación entre diferentes tipos de MI y el 
rendimiento cognitivo en la edad adulta.
Métodos: Se reclutaron 68 pacientes con TDM y 87 controles sanos. El MI se evaluó con el 
Cuestionario de trauma infantil. Se obtuvieron tres variables latentes para el rendimiento 
neuropsicológico (memoria verbal, memoria visual y función ejecutiva/velocidad de proce-
samiento) tras realizar un análisis factorial confirmatorio con las pruebas cognitivas aplica-
das. La ratio de supresión de cortisol en el test de supresión con dexametasona (DSTR) se 
realizó usando dexametasona 0,25 mg.
Resultados: Los diferentes tipos de MI tuvieron diferentes efectos sobre la cognición, 
modulados por el diagnóstico de TDM y la función del eje HHA. Los individuos con maltrato 
físico y TDM presentaron una cognición mejorada en ciertos dominios. El DSTR moduló 
diferencialmente la asociación entre memoria visual y negligencia física o abuso sexual.
Conclusiones: Los mecanismos neurobiológicos relacionados con el eje HHA que conducen 
al deterioro cognitivo pueden diferir según el tipo de MI. Nuestros resultados sugieren la 
necesidad de una evaluación e intervención tempranas sobre la cognición y los mecanismos 
de resiliencia en individuos expuestos a MI para minimizar sus efectos nocivos y duraderos.
ARTICLE HISTORY
Received 15 April 2020 
Revised 17 November 2020  
Accepted 18 November 2020
KEYWORDS
Childhood abuse; childhood 
neglect; cortisol; HPA axis; 
dexamethasone suppression 
test; cognition; memory; 
major depression
PALABRAS CLAVE
abuso infantil; negligencia 
infantil; cortisol; eje HHA; 




童年期虐待; 儿童忽视; 皮 
质醇; HPA轴; 地塞米松抑 
制试验; 认知; 记忆; 重性 
抑郁
HIGHLIGHTS 
• We studied the effects of 
childhood maltreatment 
(CM), HPA axis feedback 
(DST), and depression on 
cognition. 
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• MDD diagnosis and DST 
modulated the association 
between CM and cognition. 
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童年期虐待与下丘脑-垂体-肾上腺轴负反馈和重性抑郁障碍的相互作用: 
对认知表现的影响





知测试进行验证性因素分析后, 我们得到了3个神经心理学表现潜变量 (语言记忆, 视觉记 
忆和执行功能/处理速度) 。使用0.25mg地塞米松得到地塞米松抑制试验比率 (DSTR) 。






The hypothalamic-pituitary-adrenal (HPA) axis is 
a major physiological stress response system that 
regulates its own activity through a negative feed-
back loop exerted by cortisol. Patients with major 
depressive disorder (MDD) commonly show 
a hyperactive HPA axis (Wolkowitz, Burke, Epel, 
& Reus, 2009), including an altered feedback inhi-
bition by endogenous glucocorticoids (Pariante & 
Miller, 2001). The feedback inhibition of the HPA 
axis can be assessed with the administration of 
dexamethasone, a synthetic glucocorticoid recep-
tor agonist that results in the suppression of the 
secretion of cortisol by the adrenal gland. In 
patients with MDD, there is a lack of suppression 
of cortisol secretion after dexamethasone intake, 
which indicates a reduced feedback sensitivity and 
is considered a measure of glucocorticoid resis-
tance (Pariante & Miller, 2001; Wolkowitz et al., 
2009).
Prolonged exposure to glucocorticoids resulting 
from lowered negative feedback on the HPA axis in 
MDD has been associated with cognitive impairment 
(Behnken et al., 2013; Hansson, Murison, Lund, & 
Hammar, 2013; Zobel et al., 2004). Nevertheless, not 
all patients with MDD suffer such disturbances in the 
HPA axis feedback or in cognition, and childhood 
maltreatment (CM) is thought to be involved in this 
variability.
CM can be divided into abuse, which is an expo-
sure to threatening behaviours, and neglect, 
a deprivation of cognitive and psychosocial stimula-
tion. CM is associated with deficits in memory and 
executive function (Majer, Nater, Lin, Capuron, & 
Reeves, 2010; Nikulina & Widom, 2013), independent 
of psychopathology (R-Mercier, Masson, Bussières, & 
Cellard, 2018). Thus, neurobiological consequences of 
CM may be deemed as a potential explanation for 
poor cognitive functioning in MDD (Gould et al., 
2012; Kaczmarczyk, Wingenfeld, Kuehl, Otte, & 
Hinkelmann, 2018). Additionally, CM induces 
neurobiological changes that persist into adulthood 
and resemble the neuroendocrine features of MDD, 
including alteration of glucocorticoid receptor func-
tioning and impaired HPA axis feedback (Heim, 
Mletzko, Purselle, Musselman, & Nemeroff, 2008; 
Heim, Newport, Mletzko, Miller, & Nemeroff, 2008; 
Heim, Shugart, Craighead, & Nemeroff, 2010). 
Indeed, lasting HPA axis dysfunction related to CM 
has been found to be independent of psychopathol-
ogy (Carvalho Fernando et al., 2012; Hinkelmann 
et al., 2013; Majer et al., 2010). Therefore, it has 
been hypothesized that neuroendocrine abnormalities 
in MDD may be partly explained by the long-lasting 
effects of CM on the HPA axis and might represent 
the vulnerability for the development of depression in 
response to stress rather than consequences of 
depression (Heim, Newport et al., 2008). 
Furthermore, studies have linked CM with an 
increased risk of MDD in adulthood, predicting 
early-onset, severe, chronic and treatment-resistant 
depression (Nelson, Klumparendt, Doebler, & 
Ehring, 2017).
There is evidence that HPA axis hyper- and 
hypoactivation emerge sequentially after CM 
(Bernard, Frost, Bennett, & Lindhiem, 2017). 
Indeed, maltreated children show hypercortisolemia 
resulting from sensitization of the HPA axis after 
stress, followed by hypocortisolemia in adulthood 
due to a downregulation of the HPA system in 
response to initially high cortisol levels (Bernard 
et al., 2017). Some authors have further pointed out 
that the basal cortisol pattern may be related to the 
severity and the type of maltreatment (van der Vegt, 
van der Ende, Kirschbaum, Verhulst, & Tiemeier, 
2009). Specifically, they found that moderate CM 
was associated with morning hypercortisolemia and 
a steep diurnal cortisol slope, whereas severe CM was 
associated with hypocortisolemia and a flatter slope 
(van der Vegt et al., 2009). This effect on the HPA 
axis function was stronger for childhood abuse than 
neglect (van der Vegt et al., 2009).
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The various types of CM have also been linked to 
dysfunction of the HPA axis negative feedback in 
adulthood (Miller, Chen, & Zhou, 2007). However, 
it is not clear whether this influence ultimately leads 
to an enhancement or a suppression of cortisol secre-
tion. On the one hand, some studies have related 
emotional abuse (Carpenter et al., 2009), emotional 
neglect (Carvalho Fernando et al., 2012), or sexual 
abuse (Stein, Yehuda, Koverola, & Hanna, 1997) to 
hyper-suppression of the HPA axis in response to 
dexamethasone administration. On the other hand, 
increased cortisol responses to the Dex/CRH test 
have been reported in sexual or physical abuse 
(Heim, Mletzko et al., 2008). Lu, Gao, Huang, Li, 
and Xu (2016) found that subjects with MDD and 
CM showed decreased glucocorticoid feedback inhi-
bition compared with healthy individuals without 
MDD or CM. Not only the type of CM but also its 
severity might be critical for HPA axis responsivity in 
the Dex/CRH test. A recent study reported that 
patients with a mood disorder and mild childhood 
emotional neglect had an enhanced HPA axis 
response, while patients reporting severe neglect did 
not differ from controls in their cortisol response 
(Watson et al., 2007).
The vast majority of literature reports an associa-
tion of CM with poor performance in memory and 
executive function tasks (Dannehl, Rief, & 
Euteneuer, 2017; Majer et al., 2010; Saleh et al., 
2017; Su, D’Arcy, Yuan, & Meng, 2019). Some 
works report that the nature and magnitude of cog-
nitive deficits may vary according to the kind of 
trauma experienced (Dannehl et al., 2017; Gould 
et al., 2012; Grainger et al., 2019). In particular, it 
has been suggested by some authors that neglect 
might have more detrimental effects on cognition 
than abuse (Geoffroy, Pinto Pereira, Li, & Power, 
2016; Gould et al., 2012; Grainger et al., 2019; 
Majer et al., 2010; Nikulina & Widom, 2013), inde-
pendently of mental health (Geoffroy et al., 2016). 
Other authors have pointed out that physical abuse 
and neglect might have a more critical influence on 
memory and executive functions than emotional 
maltreatment (Dannehl et al., 2017). More counter-
intuitive associations have been found, mostly in 
samples of adults over 50 years, linking different 
types of abuse to better cognitive performance 
(Dannehl et al., 2017; Feeney, Kamiya, Robertson, 
& Kenny, 2013; Ritchie et al., 2011). Biological 
mechanisms underlying these different CM effects 
on cognition are unknown.
Although both CM and MDD may contribute to 
the cognitive dysfunction, the neurobiological 
mechanisms underlying this relationship are not yet 
fully understood. The present study aimed to assess 
the potential modulating effects of MDD diagnosis in 
the association between different types of CM and 
cognitive performance in adulthood. We hypothe-
sized that HPA axis dysfunction might play an 
important role, as neuroendocrine abnormalities 
have been related to CM as well as with MDD. 
More specifically, we hypothesized that the relation-
ship between CM and cognitive performance is 
modulated by MDD and HPA axis activity: 1) CM, 
and particularly neglect, is associated with poorer 
cognitive performance in people with MDD, and 2) 
failure to suppress cortisol levels after dexamethasone 
administration in patients with MDD and individuals 
exposed to CM is associated with poor cognitive 
performance.
2. Materials and methods
2.1. Sample
Our sample included 68 patients with MDD (67.6% 
females, mean age 59.87 ± 11.05 years) recruited from 
the Psychiatry Department at Bellvitge University 
Hospital (Barcelona) and 87 healthy controls (HC; 
66.7% females, mean age 56.14 ± 11.61 years) 
recruited from the same geographic area.
Exclusion criteria were an age less than 18 years; 
a diagnosis of other psychiatric disorders (except 
nicotine dependence), mental retardation, neurolo-
gical or severe medical conditions; pregnancy or 
puerperium; electroconvulsive therapy in the 
previous year, and corticosteroid treatment in the 
previous three months.
The sample partially overlaps with that used in 
previous studies (Labad et al., 2018; Salvat-Pujol 
et al., 2017), which explored different hypotheses.
The Bellvitge University Hospital Ethical Committee 
approved the research protocol, and all procedures 
complied with the Helsinki Declaration of 1975 (revised 
in 2013). All participants provided written informed 
consent after having received a full explanation of the 
study and acknowledged that they cannot be identified 
via the paper.
2.2. Clinical assessment
All patients were diagnosed with MDD by their 
treating psychiatrist and met DSM-IV-TR criteria 
for MDD (American Psychiatric Association, 
2000). MDD diagnosis was confirmed by an 
experienced psychiatrist using the Mini- 
International Neuropsychiatric Interview (MINI) 
(Sheehan et al., 1998). Depression severity was 
assessed with the 17-item Hamilton Depression 
Rating Scale (HDRS) (Hamilton, 1960). HC had 
no history of psychiatric disorders as assessed 
with a semi-structured interview and a score 
below 7 on the 28-item Spanish adaptation of the 
Goldberg General Health Questionnaire (GHQ-28) 
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(Lobo, Perez-Echeverria, & Artal, 1986). The 
HDRS was also administered to HC, since it was 
used as a predictive variable in the multiple linear 
regression analysis. Although some participants 
suffered CM, none met DSM-IV-TR criteria for 
PTSD (American Psychiatric Association, 2000).
Sociodemographic and clinical variables were 
assessed using a semi-structured interview. Sleep 
quality was evaluated with the Pittsburgh Sleep 
Quality Index (PSQI) (Buysse, Reynolds, Monk, 
Berman, & Kupfer, 1989). Weight and height were 
measured in all participants to calculate the body 
mass index (BMI) using the formula weight (kg)/ 
height (m2).
Exposure to CM was retrospectively assessed using 
the Childhood Trauma Questionnaire (CTQ) 
(Bernstein & Fink, 1998), which is a self-report 
inventory with 28 items rated on a five-point Likert 
scale depending on their frequency of occurrence. 
The CTQ yields a total score and scores for five 
subscales corresponding to different types of mal-
treatment (emotional, physical, and sexual abuse, 
and emotional and physical neglect). Subscale scores 
range from 5 (no history of abuse or neglect) to 25 
(history of extreme abuse or neglect). Cut-off scores 
for none, low, moderate, and severe exposure to 
maltreatment are provided for each subscale. 
Exposure to CM was determined when at least one 
CTQ subscale was rated on or above the moderate 
cut-off score (emotional abuse ≥13; physical abuse 
≥10; sexual abuse ≥8; emotional neglect ≥15; and 
physical neglect ≥10) (Bernstein & Fink, 1998). 
Cases classified as negative on all subscales were 
considered as not exposed to CM.
2.3. Neuropsychological assessment
On the same day of clinical assessment, participants 
underwent a neuropsychological evaluation to assess 
verbal memory, visual memory, processing speed and 
executive function. Table 1 includes information on 
the administered tests.
2.4. Salivary cortisol measurements
Participants collected saliva samples at home for cor-
tisol analyses shortly after clinical and neuropsycho-
logical assessments using Salivette® (Sarstedt AG & 
Co., Nümbrecht, Germany) containers and following 
the same process as in our previous studies (Labad 
et al., 2018; Salvat-Pujol et al., 2017). Eating, drink-
ing, smoking, or brushing teeth were not allowed in 
the 15 minutes prior to the collection of each sample. 
Participants were instructed to collect six saliva sam-
ples at home over two consecutive regular days, 
avoiding stressful situations and intense physical 
activity.
For the present study, two saliva samples were 
considered. Patients were asked to collect a morning 
salivary sample at 10 a.m. (day 1), take 0.25 mg of 
Table 1. Neuropsychological tests and cognitive domains assessed.
Cognitive 
domain Neuropsychological test Test description
Verbal 
memory
Hopkins Verbal Learning Test 
RevisedTM (HVLT-R)
Subjects are presented with 12 words and asked to recall as many as possible. This procedure is 
repeated three times. The outcome measure is the total number of words recalled (range 0–36).
Visual 
memory
Rey Complex Figure Test (RCFT) Subjects are asked to copy a complex line drawing and reproduce it from memory after a short 
delay (immediate recall) and after a 20–30 minute delay (delayed recall). Each reproduction is 
scored taking into account the accurate position and shape of 18 design elements (total range 
0–36). In our study, we considered scores in immediate and delayed recall, as they are measures 
of visual learning and memory.
Processing 
speed
Trail Making Test Part A (TMT-A) Subjects need to sequentially connect 25 targets (numbers 1 to 25). The outcome measure is the 
number of seconds needed to perform the task.
Brief Assessment of Cognition in 
Schizophrenia – Symbol Coding 
(BACS-SC)
As quickly as possible, participants write numbers 1 to 9 as matches to symbols on a response 
sheet for 90 seconds. The outcome measure is the total number of correct responses. This test is 
used not only in schizophrenia but also in affective disorders (Cholet et al., 2014).
Category fluency (animal naming) Participants are given 60 seconds to name as many words as possible within the animal category. 
The outcome measure is the number of unique words generated.
Stroop test (direct sub-scores for 
words)
Subjects are presented with a list of colour names (red, green, blue) written in black ink, and are 




Battery® Mazes – NAB-Mazes
There are seven mazes that become progressively more difficult. Mazes are scored based on 
completeness and completion time. Higher scores indicate better performance.
Stroop test (interference scores) After the list of colour names, a second list is presented, containing ‘Xs’ written with red, green, or 
blue ink; the subject is now asked to give the ink colour (colour sub-score). A third list contains 
words that name colours which are different to the ink colour in which the words themselves 
are written; the subject is again asked to give the ink colour (word-colour sub-score). This task 
requires subjects to inhibit the automatic response of reading and to name the colour the word 
is written in. After obtaining these sub-scores, an interference score is calculated, which is the 
difference between real and expected interference. Positive scores indicate adequate inhibition 
of automatic responses, while negative scores indicate that the subject has inhibited worse than 
expected.
Corsi Block-Tapping Test (CBTT) Ten cubes arranged on a board are presented to the subject. The examiner taps pre-defined 
progressively longer sequences. The subject is asked to repeat the tapping sequence, forwards 
and backwards. The outcome measure is the total number of correct items (range 0–32).
For all tests, higher scores reflect better cognitive performance, with the exception of TMT-A, in which higher scores reflect poorer cognitive 
performance. 
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dexamethasone at 11 p.m. on the same day (day 1) 
and collect another salivary sample at 10 a.m. on 
the day after (day 2). Another sample was taken 
immediately before the neuropsychological assess-
ment, which was performed in one morning (mean 
[SD] starting time 10:37 [00:51] a.m.) prior to home- 
collection cortisol sampling.
Samples were stored in refrigerators and returned 
personally by each participant. After the Salivettes 
were received, they were stored at −20°C and later 
sent to the BioBanc from the Institut d’Investigació 
Sanitària Pere Virgili (IISPV) for centrifugation 
(3000 rpm for 5 min) and aliquotation, after which 
they were frozen at −20°C until analysis by enzyme- 
linked immunosorbent assay (IBL International, 
Hamburg, Germany) to determine saliva cortisol 
levels.
The feedback inhibition of the HPA axis was 
assessed with the dexamethasone suppression test 
(DST). The cortisol suppression ratio in the DST 
(DSTR) was defined as the ratio [cortisol at 10 a.m. 
on day 1]/[cortisol at 10 a.m. on day 2 (post dexa-
methasone)]. The DSTR provides information about 
the negative feedback system of the HPA axis. Higher 
DSTR values indicate greater suppression of cortisol 
secretion after dexamethasone administration, and 
a lack of suppression is considered a measure of 
glucocorticoid resistance.
The DSTR was assessed using a very low dose of 
dexamethasone (0.25 mg), much lower than the 
conventional 1 mg used in plasma analyses. The 
reasons for this decision were as follows: (1) sali-
vary cortisol presents more profound suppression 
than does plasma cortisol or plasma ACTH in 
a dose–response pattern after different doses of 
dexamethasone are admistered; although the rea-
sons for the greater salivary cortisol suppression 
by dexamethasone are not clear, the binding of 
plasma cortisol by cortisol-binding globulin might 
limit the amount of free diffusible cortisol, so that 
saliva cortisol levels fall more rapidly than the total 
plasma cortisol concentration (Castro, Elias, Elias, 
& Moreira, 2003); (2) higher dexamethasone doses 
are expected to completely suppress the axis and 
are more likely to result in reproducibly undetect-
able cortisol levels; previous studies (Reynolds 
et al., 1998) using 0.25 mg doses have reported 
post dexamethasone cortisol levels that are well 
within the detection limits of cortisol assays, show-
ing approximately 30% suppression and greater 
within-subject variability; (3) we were interested 
in exploring DST as a continuous measure (cortisol 
suppression ratio), and the use of more conven-
tional dexamethasone doses would not have 
allowed us to detect subtle alterations in cortisol 
secretion regulation.
2.5. Statistical analyses
Data processing was performed using SPSS 21 (SPSS, 
IBM, USA). We normalized the data as described in 
previous works (Labad et al., 2018; Salvat-Pujol et al., 
2017).
To reduce the number of cognitive variables and 
statistical models, we conducted a confirmatory 
factor analysis (CFA) with R (version 3.5.2 
[December 2018]) using the lavaan (version 0.6-4 
[July 2019]) and semPlot (version 1.1.2 
[August 2019]) packages. We considered three 
latent variables that included information on cog-
nitive tasks in three different domains: verbal 
memory, visual memory and executive function/ 
processing speed (Figure 1). This later factor 
resulted from the combination of two latent vari-
ables (executive functioning and processing speed). 
The reason for combining both latent variables was 
because of the known relationship between proces-
sing speed and executive functioning (Albinet, 
Boucard, Bouquet, & Audiffren, 2012), and because 
this combination improved the fitting of the CFA 
model. The variances of all latent variables were set 
equal to one to standardize the model. Three fit 
indexes were considered: Chi-square (χ2), 
Comparative Fit Index (CFI), and Standardized 
Root Mean Square Residual (SRMR). Ideally, for 
a model that fits the data, the χ2 would not be 
significant (p > 0.05) (Iacobucci, 2010). CFI values 
>0.90 indicate a reasonably good fit of the SEM 
model (Hu & Bentler, 1999). SRMR represents the 
standardized difference between the observed cor-
relation and the predicted correlation. A SRMR 
value <0.08 is generally considered a good fit (Hu 
& Bentler, 1999). However, as these indexes, parti-
cularly χ2, are affected by sample size, some authors 
have suggested adjusting χ2 by the degrees of free-
dom (df) (Iacobucci, 2010). A model demonstrates 
a reasonable fit if χ2/df ≤ 3. Our CFA model 
showed the following fitting indexes: χ2 = 72.655, 
df = 49, p = 0.016; CFI = 0.981; SRMR = 0.048, 
which indicate a good fit, as χ2/df was 1.48. Three 
factor scores (one for each main latent variable) 
were computed with the lavPredict() function.
Categorical data among groups (MDD vs. HC) 
were compared with Chi-square tests, and T-tests 
for independent samples were applied to compare 
continuous variables.
We performed exploratory partial correlation 
analyses stratified by diagnosis and adjusted by gen-
der, age, and years of education to explore the rela-
tionship between CM (CTQ scores on emotional, 
physical and sexual abuse, and emotional and phy-
sical neglect), cognitive performance (latent vari-
ables extracted from the CFA) and DSTR. As these 
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analyses were exploratory in nature, we did not 
correct for multiple comparisons (Bender & Lange, 
2001).
We performed separate multiple linear regression 
(MLR) analyses for each latent variable obtained in 
the CFA, including all participants, to explore the 
association of cognitive performance with different 
types of CM and to assess the potential modulating 
effects of MDD diagnosis and HPA axis negative 
feedback in the relationship between different types 
of CM and cognitive performance. We controlled 
for potential confounders, including gender, age, 
years of education, BMI, tobacco consumption, 
sleep quality, HDRS scores and cortisol levels at 
the time of neuropsychological assessment (Salvat- 
Pujol et al., 2017). All independent variables were 
entered into the equation. Interaction terms 
between CM, DSTR, and MDD diagnosis were 
tested in a final step. Only significant interaction 
terms were kept in the final equation. The statistical 
significance level was set at p < 0.05 (bilateral).
3. Results
3.1. Clinical data
The demographic and clinical variables for the two 
study groups are described in Table 2. MDD patients 
were older (t(153) = −2.024, p = 0.045), had a lower 
educational level (t(153) = 4.480, p < 0.001), higher 
BMI (t(152) = −2.631, p = 0.009) and reported poorer 
sleep quality (t(139) = −5.005, p < 0.001) than HC. 
Total CTQ scores were higher in MDD patients than 
in HC (t(153) = −2.111, p = 0.036).
3.2. HPA axis function and cognition
Cortisol and cognitive measures are described in Table 
3. HPA axis measures did not differ between groups, 
except for cortisol salivary concentrations the morning 
after dexamethasone administration (t(153) = −2.123, 
p = 0.035), which were higher in MDD patients. HC 
performed better than MDD patients in all cognitive 
tasks.
3.3. Partial correlation analyses
CM, cognitive and cortisol variables did not correlate 
with each other (see Supplementary Tables 1 and 2 
online).
3.4. Multiple linear regression analyses
Table 4 displays the results of the MLR analyses.
3.4.1. Verbal memory
MDD diagnosis had a negative effect on verbal mem-
ory (β = −0.679, p < 0.001). However, the DSTR 
Figure 1. Confirmatory factor analysis of neuropsychological variables. We considered three latent variables that included 
information of cognitive tasks in three different domains: verbal memory, visual memory and executive function/processing 
speed. Our CFA model showed the following fitting indexes: χ2 = 72.655, df = 49, p = 0.016; CFI = 0.981; SRMR = 0.048.
Abbreviations: BACS-SC: Brief Assessment of Cognition in Schizophrenia – Symbol Coding; CBTT: Corsi Block-Tapping Test; HVLT-R_1, HVLT-R_2, 
HVLT-R_3: Hopkins Verbal Learning Test RevisedTM, trials 1, 2 and 3; NAB-Mazes: Neuropsychological Assessment Battery® Mazes; RCFT_DR: Rey 
Complex Figure Test, delayed recall; RCFT_IR: Rey Complex Figure Test, immediate recall; TMT-A: Trail Making Test Part A. 
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modulated this relationship (β = 0.182, p = 0.031), 
reflecting that a greater suppression after dexametha-
sone administration in MDD patients exerted 
a positive effect on this cognitive domain.
Meanwhile, CTQ scores in physical abuse 
(β = 0.182, p = 0.017) and sexual abuse (β = 0.134, 
p = 0.040) were positively associated with verbal 
memory performance, but without significant inter-
actions with DSTR or depression diagnosis.
Physical neglect negatively affected verbal memory 
(β = −0.409, p < 0.001). Nevertheless, the interaction 
between physical neglect and depression diagnosis 
(β = 0.621, p = 0.002) suggests that higher physical 
neglect scores were associated with enhanced verbal 
memory in MDD patients.
3.4.2. Visual memory
Depression diagnosis (β = −0.669, p = 0.002) was 
associated with poorer visual memory performance.
Physical abuse (β = −0.270, p = 0.045) and physical 
neglect (β = −0.286, p = 0.007) negatively affected 
Table 2. Demographic data and clinical variables by study groups.
HC MDD Statistics
n = 87 n = 68 (T-test/χ2)
Age (years) 56.14 (11.61) 59.87 (11.05) t(153) = −2.024, p = 0.045
Female gender, n (%) 58 (66.7) 46 (67.6) χ2 = 0.017, p = 1.000
Education (years) 12.11 (3.95) 9.16 (4.23) t(153) = 4.480, p < 0.001
BMI (kg/m2) 26.80 (4.90) 28.87 (4.75) t(152) = −2.631, p = 0.009
PSQI 5.26 (3.37) 8.75 (4.92) t(139) = −5.005, p < 0.001
Substance use
Smoking, n (%) 14 (16.1) 15 (22.1) χ2 = 1.006, p = 0.405
Tobacco consumption (cigarettes/day) 2.15 (6.63) 3.51 (8.14) t(153) = −1.150, p = 0.252
Daily alcohol intake, n (%) 29 (33.3) 20 (29.4) χ2 = 0.147, p = 0.729
Daily alcohol intake (g/day) 2.70 (6.36) 2.02 (4.24) t(136) = 0.710, p = 0.479
Clinical variables of depression
HDRS 0.70 (1.15) 9.56 (8.70) t(153) = −9.398, p < 0.001
Suicide attempts, n (%) 0 (0.0) 14 (20.6) χ2 = 19.690, p < 0.001
Age at onset (years) NA 42.02 (12.79) NA
Melancholic symptoms, n (%) NA 56 (82.4) NA
Atypical symptoms, n (%) NA 3 (4.40) NA
Psychotic symptoms, n (%) NA 3 (4.40) NA
Number of depressive episodes NA 3.91 (2.73) NA
Number of hospitalizations NA 0.55 (1.54) NA
Childhood Trauma Questionnaire n (%) mean (SD) n (%) mean (SD)
CTQ – emotional abuse 7 (8.0) 7.11 (2.97) 10 (14.7) 8.12 (4.30) χ2 = 1.734, p = 0.206; t(153) = −1.715, p = 0.088
CTQ – physical abuse 4 (4.6) 5.86 (1.68) 8 (11.8) 6.40 (3.51) χ2 = 2.745, p = 0.131; t(153) = −1.252, p = 0.213
CTQ – sexual abuse 8 (9.2) 5.56 (1.25) 8 (11.8) 5.93 (2.94) χ2 = 0.272, p = 0.607; t(153) = −1.040, p = 0.300
CTQ – emotional neglect 8 (9.2) 9.13 (4.07) 9 (13.2) 10.29 (4.13) χ2 = 0.638, p = 0.448; t(153) = −1.762, p = 0.080
CTQ – physical neglect 8 (9.2) 6.33 (2.21) 10 (14.7) 7.00 (2.60) χ2 = 1.129, p = 0.320; t(153) = −1.722, p = 0.087
CTQ – total score 34.00 (8.61) 37.74 (13.33) t(153) = −2.111, p = 0.036
Exposed to CM 22 (25.3) 22 (32.4) χ2 = 0.937, p = 0.372
Abbreviations: HC, healthy controls; MDD, major depressive disorder; BMI, body mass index; PSQI, Pittsburgh Sleep Quality Index; HDRS, Hamilton 
Depression Rating Scale; CTQ, Childhood Trauma Questionnaire. 
All variables presented in mean (SD) or n (%). 
NA: non applicable. 
Table 3. Cortisol measures and neuropsychological variables by study groups.
HC MDD
T-testn = 87 n = 68
Cortisol measures
10-h cortisol (nmol/L) 11.06 (9.72) 12.27 (8.22) t(146) = −1.011, p = 0.314
10-h post-DXM cortisol (nmol/L) 4.55 (4.68) 6.50 (7.82) t(153) = −2.123, p = 0.035
DSTR† 9.97 (20.06) 5.91 (9.71) t(153) = 1.319, p = 0.189
Cortisol at NPS (nmol/L) 10.53 (5.79) 13.11 (9.75) t(149) = −1.208, p = 0.229
Cognitive domains
Latent variable 1 (verbal memory) 0.43 (1.32) −0.54 (1.24) t(153) = 4.664, p = <0.001
Latent variable 2 (visual memory) 2.35 (6.37) −3.00 (6.15) t(153) = 5.265, p = <0.001
Latent variable 3 (executive function/processing speed) 5.19 (11.12) −6.64 (13.02) t(153) = 6.101, p = <0.001
Abbreviations: HC, healthy controls; MDD, major depressive disorder; DXM, dexamethasone; NPS, neuropsychological assessment; 
DSTR, dexamethasone suppression test ratio. 
All variables presented in mean (SD). 
Cortisol raw scores and untransformed DSTR are shown, outliers excluded. P values calculated upon transformed cortisol and DSTR values, outliers 
excluded. 
†DSTR = 10-h cortisol/10-h post-DXM cortisol. 
Latent variable 1 (verbal memory) includes the 3 subscores of the Hopkins Verbal Learning Test – Revised (HVLT-R). 
Latent variable 2 (visual memory) includes scores of immediate and delayed recall of the Rey Complex Figure Test (RCFT). 
Latent variable 3 (executive function/processing speed) includes scores on Neuropsychological Assessment Battery® Mazes (NAB-Mazes), STROOP 
interference task, and Corsi Block-Tapping Test for executive function; and category fluency, Brief Assessment of Cognition in Schizophrenia – Symbol 
Coding (BACS-SC), Trail Making Test part A, and STROOP word subscore for processing speed. 
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visual memory, but significant interactions were 
found with DSTR or MDD diagnosis. More specifi-
cally, physical neglect interacted with DSTR 
(β = 0.538, p = 0.018); participants with higher phy-
sical neglect scores and greater suppression after dex-
amethasone intake showed better performance in 
visual memory. In turn, the significant interaction 
between physical abuse and depression diagnosis for 
visual memory (β = 0.551, p = 0.025) suggested that 
MDD patients with higher physical abuse scores 
showed better performance in this cognitive domain.
Sexual abuse was positively associated with visual 
memory (β = 0.252, p = 0.009). However, DSTR had 
a modulation effect (β = −0.919, p = 0.028), suggesting 
poorer visual memory performance in participants with 
higher sexual abuse scores and greater DSTR.
3.4.3. Executive function/processing speed
MDD diagnosis (β = −0.136, p = 0.048) had a negative 
effect on executive function/processing speed.
Sexual abuse (β = 0.157, p = 0.006) and physical 
neglect (β = −0.161, p = 0.023) differentially affected 
executive function/processing speed.
No interactions between CM and DSTR or MDD 
diagnosis were found for these cognitive domains.
4. Discussion
Apart from a study reporting cognitively beneficial 
effects of cortisol administration in depressed women 
with CM (Abercrombie et al., 2018), to our knowl-
edge, no other studies have assessed the role of MDD 
diagnosis or HPA axis negative feedback in the asso-
ciation between different types of CM and cognitive 
performance in adulthood.
The present study confirmed disturbed cognitive 
performance in depression (Rock, Roiser, Riedel, & 
Blackwell, 2014). Although post-dexamethasone cor-
tisol levels were higher in patients with MDD, the 
ratio of cortisol suppression did not confirm an 
impaired feedback sensitivity (Salvat-Pujol et al., 
2017). Our results are in part similar to previous 
findings reporting few differences in cortisol levels 
(Strickland, Morriss, Wearden, & Deakin, 1998) or 
the DSTR (Carvalho Fernando et al., 2012) between 
depressed and non-depressed subjects. Total CTQ 
scores were higher in MDD patients than in HC, in 
accordance with previous studies that linked depres-
sion with higher levels of CM (Chapman et al., 2004). 
Despite these findings, we did not find any significant 
differences between groups in any of the CTQ sub-
scale scores.
Table 4. Results of multiple linear regression analyses exploring the association between childhood maltreatment, HPA axis 
function, MDD diagnosis, and cognitive performance.
Latent variable 1 Latent variable 2 Latent variable 3
Verbal memory Visual memory Executive function and processing speed
R2 final model = 0.594 R2 final model = 0.502 R2 final model = 0.686
β p β p β p
Gender 0.127 0.057 −0.181 0.015 −0.059 0.305
Age −0.464 <0.001 −0.425 <0.001 −0.447 <0.001
Years of education 0.200 0.007 0.189 0.022 0.364 <0.001
BMI 0.020 0.763 0.048 0.535 −0.034 0.561
Tobacco consumption (cig/day) 0.026 0.695 −0.099 0.180 −0.014 0.809
HDRS scores −0.207 0.028 −0.079 0.450 −0.132 0.103
MDD diagnosis −0.679 0.001 −0.669 0.002 −0.136 0.048
PSQI −0.176 0.028 −0.075 0.395 −0.070 0.304
CTQ- emotional abuse −0.108 0.212 0.052 0.584 −0.080 0.283
CTQ- physical abuse 0.182 0.017 −0.270 0.045 0.082 0.213
CTQ- sexual abuse 0.134 0.040 0.252 0.009 0.157 0.006
CTQ- emotional neglect 0.094 0.267 −0.101 0.285 0.069 0.347
CTQ- physical neglect −0.409 <0.001 −0.286 0.007 −0.161 0.023
DSTR† −0.075 0.286 0.316 0.485 −0.023 0.657
Cortisol at NPS# (T7) 0.007 0.912 0.028 0.690 0.011 0.840
MDD diagnosis x CTQ- physical neglect 0.621 0.002 NA NA NA NA
MDD diagnosis x CTQ- physical abuse NA NA 0.551 0.025 NA NA
MDD diagnosis x DSTR† 0.182 0.031 NA NA NA NA
DSTR† x CTQ- physical neglect NA NA 0.538 0.018 NA NA
DSTR† x CTQ- sexual abuse NA NA −0.919 0.028 NA NA
Latent variable 1 (verbal memory) includes the 3 subscores of the Hopkins Verbal Learning Test – Revised (HVLT-R). 
Latent variable 2 (visual memory) includes scores of immediate and delayed recall of the Rey Complex Figure Test (RCFT). 
Latent variable 3 (executive function/processing speed) includes scores on Neuropsychological Assessment Battery® Mazes (NAB-Mazes), STROOP 
interference task, and Corsi Block-Tapping Test for executive function; and category fluency, Brief Assessment of Cognition in Schizophrenia – Symbol 
Coding (BACS-SC), Trail Making Test part A, and STROOP word subscore for processing speed. 
Neuropsychological variables were considered as the dependent variables. 
β: standardized beta coefficient. 
Abbreviations: BMI, body mass index; HDRS, Hamilton Depression Rating Scale; MDD, major depressive disorder; PSQI, Pittsburgh Sleep Quality Index; 
CTQ, Childhood Trauma Questionnaire; DSTR, dexamethasone suppression test ratio; NPS, neuropsychological assessment; NA, not applicable. 
† DSTR = 10-h cortisol/10-h post-dexamethasone cortisol. 
# Transformed cortisol values. 
Non-significant interaction terms were excluded in the final equation. 
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Physical maltreatment and sexual abuse had dif-
ferent neurobiological effects on cognition, although 
these effects, according to our hypothesis, were 
modulated by HPA axis function and MDD 
diagnosis.
Physical neglect was associated with poorer cogni-
tive performance, in accordance with previous litera-
ture (Dannehl et al., 2017; Geoffroy et al., 2016; Majer 
et al., 2010; Nikulina & Widom, 2013). Physical abuse 
did not show a consistent association with cognitive 
performance in different domains. In contrast, sexual 
abuse was associated with enhanced cognition. 
Although most studies indicate that sexual abuse 
decreases cognitive performance (Dannehl et al., 
2017; Gould et al., 2012), others found that it did 
not predict poorer executive function (Nikulina & 
Widom, 2013) or even concluded that sexual abuse 
is associated with better global cognition, memory, 
executive function, and processing speed (Feeney 
et al., 2013). In the latter study, performed in adults 
aged 50 years and older, authors argue that other 
studies rely on younger participants, in whom the 
abuse experience is fresher and its impact greater 
(Feeney et al., 2013). Previous research indicates 
that older adults tend to be more stress-resilient 
than younger individuals, probably due to prior 
experience with stressors, more effective coping stra-
tegies, greater tolerance for negative affect, and better 
emotion regulation (Feeney et al., 2013; Seery, 
Holman, & Silver, 2010). These findings are consis-
tent with stress inoculation and resilience theories. 
Early exposure to stress has been mostly related to an 
increased risk for the development of psychopathol-
ogy after experiencing subsequent stressors in adult-
hood (Heim, Newport et al., 2008). This is because 
early life stress alters corticolimbic brain systems that 
regulate stress and anxiety, disrupts the acquisition of 
appropriate coping styles, induces alterations in base-
line activity as well as stress reactivity of the HPA 
axis, diminishes the volumes of the hippocampus and 
the prefrontal cortex (Stein, Koverola, Hanna, 
Torchia, & McClarty, 1997; Van Harmelen et al., 
2010), and impairs cognition (Heim, Newport et al., 
2008; Majer et al., 2010; McEwen, 2007; Nikulina & 
Widom, 2013; Pryce, Dettling, Spengler, Spaete, & 
Feldon, 2004; Pryce et al., 2005), independent of 
psychopathology (R-Mercier et al., 2018). There is 
evidence that prior exposure to moderate (but not 
minimal or substantial) stress levels, which are chal-
lenging enough to evoke acute anxiety and transiently 
activate the HPA axis, fosters the development of 
resilience to subsequent stressors encountered later 
in life (Parker, Buckmaster, Hyde, Schatzberg, & 
Lyons, 2019; Parker & Maestripieri, 2011). Thus, the 
relationship between early life stress exposure and 
subsequent resilience can be depicted as a non- 
linear J-shaped function (Parker et al., 2019). 
Factors such as sex, predictability of the stress, 
degree, duration, nature, and developmental timing 
of the historical stress exposure can influence the 
shape and inflection point of the J-shaped curve 
(Luine, 2002; Parker & Maestripieri, 2011). 
Longitudinal studies of animal development support 
the notion that intermittent stressful experiences 
early in life (a laboratory manipulation called ‘stress 
inoculation’) enhance long-lasting adaptive function-
ing, diminishing neurobiological responses to mod-
erate stress and enhancing cognitive control of 
behaviour (Lyons, Parker, & Schatzberg, 2010). 
Prefrontal corticolimbic brain circuits have been 
implicated in resilience, as they play a role in cogni-
tive control and regulate the HPA axis stress response 
(Diorio, Viau, & Meaney, 1993; Konishi, Nakajima, 
Uchida, Sekihara, & Miyashita, 1998; Miller, 2000; 
Sullivan & Gratton, 2002). Most studies report that 
early life stress inoculation promotes the develop-
ment of larger prefrontal cortical volumes later in 
life without affecting hippocampal volumes (Katz 
et al., 2009; Lyons, Afarian, Schatzberg, Sawyer- 
Glover, & Moseley, 2002; Lyons, Yang, Sawyer- 
Glover, Moseley, & Schatzberg, 2001), which may be 
due to the growth and development of the prefrontal 
cortex extending into early adulthood, while hippo-
campal growth and development occurs primarily in 
utero (Giedd et al., 1999; Khazipov et al., 2001). 
Nevertheless, some studies suggest that stress during 
childhood increases hippocampal neurogenesis (Hays 
et al., 2012). Even though there is some controversy 
on whether stress inoculation affects the hippocampal 
structure, evidence from animal studies suggests that 
stress resilience may be mediated by increased hippo-
campal glucocorticoid receptor expression: 
a functional hippocampus adequately inhibits the 
HPA axis response to subsequent acute stressors 
(Kaffman & Meaney, 2007; Parker & Maestripieri, 
2011). These findings suggest that stress inoculation 
may either directly alter the neural substrates 
involved in adaptive functioning and cognitive func-
tion, or indirectly influence cognitive performance by 
primarily changing emotion regulation (Lyons, 
Parker, Katz, & Schatzberg, 2009; Parker & 
Maestripieri, 2011). Brain changes observed after 
early stress constitute neuroplastic adaptive responses 
to facilitate survival rather than non-specific damage, 
reflecting stress resilience rather than stress pathol-
ogy, and this stress inoculation phenotype persists 
into adulthood (Parker, Buckmaster, Lindley, 
Schatzberg, & Lyons, 2012; Parker, Buckmaster, 
Sundlass, Schatzberg, & Lyons, 2006; Teicher & 
Samson, 2016). Considering all these findings, and 
since cognitive tasks assessed in our study involve 
the hippocampus and the prefrontal cortex, we con-
clude that the speculatively resilient individuals who 
have suffered sexual abuse in our sample may have 
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a more functionally preserved hippocampus and pre-
frontal cortex, which would enable a greater ability to 
successfully adapt to stress. Thus, we could be obser-
ving a cognitive phenotype in which individuals with 
sexual abuse raised in an enriching environment, 
which has positive effects in neurodevelopment (van 
Praag, Kempermann, & Gage, 2000), may present 
with preserved cognitive performance.
According to a recent study by Trauelsen et al., 
(2019), and very surprisingly, performance on cold 
cognitive (neurocognitive) tasks might not be the 
only ones enhanced in individuals with sexual 
abuse: although in first-episode psychosis, better 
metacognition abilities were reported in subjects 
with CM, including sexual abuse (Trauelsen et al., 
2019). The authors suggested that insight could play 
a role in this association, and recommended future 
studies to include hot (social cognition) and cold 
cognition assessment. Even though our study was 
performed in patients with MDD and did not take 
into account metacognition, it is interesting the fact 
that findings on the link between sexual abuse and 
enhanced cognition are somehow shared. Future 
longitudinal studies are needed to further assess and 
clarify the effects of sexual abuse on cognitive abil-
ities, taking into account different types of cognition 
and the insight of the subject.
Cortisol suppression after dexamethasone was not 
related to cognitive function. Previous literature has 
yielded contradictory findings on this issue. 
Specifically, while some studies suggest that lower 
cortisol suppression with the Dex/CRH could be 
related to poorer executive functioning in recovered 
MDD patients (Behnken et al., 2013), others report 
no association between cortisol suppression and 
executive function (Hansson et al., 2013; Krogh 
et al., 2012) or visual memory (Krogh et al., 2012) 
using the DST with dexamethasone 1 mg.
Surprisingly, we observed a different effect of 
DSTR in its interaction with physical neglect and 
sexual abuse on visual memory. DSTR showed an 
association with better visual memory in physically 
neglected individuals, reflecting that a more pre-
served HPA axis function would imply a more func-
tionally preserved hippocampus and that despite the 
history of neglect, individuals would be able to sus-
tain an adequate cognitive performance. Nonetheless, 
the interaction of DSTR with sexual abuse indicates 
that in those participants with sexual abuse, greater 
suppression of the HPA axis is associated with poorer 
cognitive performance.
The distinct modulation of sexual abuse and 
physical neglect by DSTR reinforces the idea that 
these experiences have a different impact on the 
HPA axis and, most likely, cognition. These find-
ings suggest that potential HPA axis-related neuro-
biological mechanisms leading to cognitive 
impairment might differ depending upon the type 
of childhood trauma: a GR resistance (reduced 
HPA axis negative feedback) would be pathological 
in people with a history of physical neglect, 
whereas the pathological condition would be the 
opposite in people with a history of sexual abuse, 
as increased GR binding (enhanced HPA axis nega-
tive feedback) was associated with a poorer cogni-
tive outcome. This last finding is in accordance 
with classical studies reporting an enhanced dexa-
methasone cortisol suppression in women victims 
of sexual abuse (Stein et al., 1997).
Depression diagnosis negatively impacted cognition, 
but physical maltreatment modulated this relationship. 
Contrary to our expectations, individuals with physical 
maltreatment and MDD presented with enhanced cog-
nition in certain domains depending on whether 
experienced maltreatment was abuse (visual memory) 
or neglect (verbal memory). Again, and according to 
Trauelsen findings and their interpretation (Trauelsen 
et al., 2019), patients who recognized physical maltreat-
ment might be endowed with higher insight and, 
although speculative, be more resilient. This resiliency, 
coupled with the fact that maltreatment itself may lead 
to adaptive cognitive responses, could partially explain 
these results. Our findings might be supported by the 
observation that the absence of major psychopathology 
does not comprise an adequate indicator of resilience 
(Simeon et al., 2007). Future studies are needed to 
address these issues.
Upon examination of the significant interaction 
between DSTR and MDD diagnosis on cognition, 
we found that a greater suppression after dexa-
methasone administration in MDD patients was 
associated with enhanced verbal memory. Cortisol 
non-suppression in response to dexamethasone, 
suggesting lower sensitivity of the HPA axis nega-
tive feedback, has been reported in 40–60% of 
depressed patients (Carroll et al., 1981). Classical 
studies have reported better cognitive outcomes in 
MDD patients with greater dexamethasone sup-
pression (Wauthy, Ansseau, von Frenckell, 
Mormont, & Legros, 1991). Although it is some-
what speculative, those patients with a more pre-
served HPA axis function (e.g. greater cortisol 
suppression to dexamethasone) will most likely 
present with higher integrity of the hippocampus 
and, hence, better cognitive performance in hippo-
campus-dependent cognitive tasks.
4.1. Limitations and methodological issues
Some limitations and methodological issues need to 
be considered. All patients received antidepressant 
treatment according to their clinical needs and there 
were no drug-naïve patients in our sample. We are 
aware that this treatment may have impacted cortisol 
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or cognitive measures (Jain et al., 2019; Rosenblat, 
Kakar, & McIntyre, 2015). However, the fact that we 
still found differences in cognitive performance in 
patients treated with antidepressants suggests that 
our findings in drug-naïve patients could be even 
stronger. Additionally, the fact that patients were in 
a naturalistic setting could facilitate the extrapolation 
of our results to clinical populations. Patients were 
recruited from a tertiary source, that may differ from 
community-based cases, thereby limiting the general-
ization of these results.
Although some have indicated that the CTQ and 
the PSQI could be influenced by recall bias or 
a depressive state, they are validated psychometric 
instruments with good internal consistency and valid-
ity and suitable for clinical and research settings 
(Buysse et al., 1989; Majer et al., 2010).
Cortisol measures were assessed only once. 
Although we did not repeat the DST on different 
days, this HPA axis dynamic test has shown 
a relatively good individual stability over time 
(Golden, Wand, Malhotra, Kamel, & Horton, 2011; 
Huizenga et al., 1998).
Finally, the cross-sectional design precludes causal 
inferences, and longitudinal studies are needed to 
address this issue. Other variables that could modu-
late the relationship between MDD diagnosis, CM 
and cognitive function should be considered in future 
studies, including polymorphisms of genes implicated 
in the HPA axis or resilience, inflammation para-
meters, structural and functional neuroimaging, and 
personality traits. The results on these issues may 
provide greater knowledge and a more effective clin-
ical assessment and management of individuals with 
a history of CM.
4.2. Conclusions
As overall conclusions, physical maltreatment and 
sexual abuse had different neurobiological effects on 
cognition, with modulating effects by HPA axis func-
tion and MDD diagnosis. Meanwhile, emotional mal-
treatment did not have an impact on cognitive 
performance and it did not interact with DSTR or 
depression diagnosis. Thus, CM and its subtypes 
should be taken into account in studies involving 
cognition, HPA axis function and psychopathology.
Our results suggest a need for early assessment and 
intervention on cognition and resilience mechanisms 
in individuals exposed to CM to minimize its deleter-
ious and lasting effects. Since CM is thought to 
increase the risk of MDD and influence its clinical 
course, our findings may add to the knowledge of the 
aetiology, prevention and treatment of depression.
In addition, there is increasing evidence that CM 
shapes biological stress response systems, including 
the HPA axis. Consequently, the HPA axis might 
become a potential target for specific treatment inter-
ventions in patients with CM (Menke, 2019).
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